T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding T2 Biosystems, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 21 | 26 | +5 |
| Shares | 2.15M | 871.8K | −1.28M (−59.5%) |
| Value | $4.24M | $365.9K | −$3.87M (−91.4%) |
New holders (9)
Institutions that held T2 Biosystems, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 92,983 | $39.1K | 0.00% |
| Virtu Financial LLC | 31,162 | $13.0K | 0.00% |
| Two Sigma Securities, LLC | 22,814 | $9.58K | 0.00% |
| Kingswood Wealth Advisors, LLC | 20,000 | $8.40K | 0.00% |
| Two Sigma Investments, LP | 11,936 | $5.01K | 0.00% |
| Nordwand Advisors, LLC | 10,000 | $4.20K | 0.00% |
| Citigroup Inc | 237 | $100 | 0.00% |
| SBI Securities Co., Ltd. | 99 | $42 | 0.00% |
| JPMorgan Chase & Co | 33 | $14 | 0.00% |
Sold out (4)
Institutions that held T2 Biosystems, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Armistice Capital, LLC | 1,396,000 | $2.75M |
| Millennium Management LLC | 39,140 | $77.1K |
| IFP Advisors, Inc | 1 | $2 |
| International Assets Investment Management, LLC | 65 | – |